查看文章

Cervical cancer screening laboratory practices may evolve with new terminology and technologies.

To investigate changes in cervical cytopathology practice resulting from the 2014 Bethesda System updates and screening technologies.

Questionnaires accompanied 2016 and 2017 mailings of the College of American Pathologists PAP Education program.

In 2016, most laboratories surveyed had adopted or were planning to adopt 2014 Bethesda System updates, and the majority (53%; 365 of 689) used an age cutoff of 45 for reporting benign-appearing endometrial cells. However, 51.3% (354 of 690) of laboratories used the term low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion, for cases with indeterminate features, and 44.9% (298 of 664) of …